MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells

Cisplatin chemoresistance is a clinical obstacle in the treatment of gastric cancer (GC). Enhanced DNA repair capacity may lead to cisplatin resistance. However, the detailed molecular mechanism of GC cisplatin resistance specifically involving nucleotide excision repair (NER) is not clear. However,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cancer
Auteurs principaux: Xie, Xiaoque, Huang, Nana, Zhang, Yiyin, Wei, Xiaoli, Gao, Mengru, Li, Min, Ning, Jie, Liu, Wei, Zhao, Qihong, Wang, Hua, Gu, Kangsheng
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2019
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400793/
https://ncbi.nlm.nih.gov/pubmed/30854110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.25814
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires